Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Gasparini

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonismNathalie Breysse, Christelle Baunez, Will Spooren, et al.
Psychopharmacology|February 18, 2005
Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodentsMichelle E Page, Paul Szeliga, Fabrizio Gasparini, et al.
Advances in Experimental Medicine and Biology|February 11, 2003
Neuroprotective activity of metabotropic glutamate receptor ligandsPeter J Flor, Giuseppe Battaglia, Ferdinando Nicoletti, et al.
Journal of Neuroinflammation|August 24, 2016
Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytesSinead A O'Sullivan, Fabrizio Gasparini, Anis K Mir, et al.
Addiction Biology|March 12, 2011
Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in ratsAmine Bahi, Katharina Fizia, Monika Dietz, et al.
BMC Medical Genetics|March 9, 2012
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitroElisabetta Tabolacci, Filomena Pirozzi, Baltazar Gomez-Mancilla, et al.
Psychopharmacology|December 17, 2004
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in ratsPaul J Kenny, Benjamin Boutrel, Fabrizio Gasparini, et al.
Neuropharmacology|January 16, 2010
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeysNicolas Morin, Laurent Grégoire, Baltazar Gomez-Mancilla, et al.
Neuroimage|February 27, 2019
Inhibiting mGluR5 activity by AFQ056/Mavoglurant rescues circuit-specific functional connectivity in Fmr1 knockout miceValerio Zerbi, Marija Markicevic, Fabrizio Gasparini, et al.
Psychopharmacology|November 16, 2013
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug developmentAndreea S Pop, Baltazar Gomez-Mancilla, Giovanni Neri, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonismNathalie Breysse, Christelle Baunez, Will Spooren, et al.
Psychopharmacology|February 18, 2005
Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodentsMichelle E Page, Paul Szeliga, Fabrizio Gasparini, et al.
Advances in Experimental Medicine and Biology|February 11, 2003
Neuroprotective activity of metabotropic glutamate receptor ligandsPeter J Flor, Giuseppe Battaglia, Ferdinando Nicoletti, et al.
Journal of Neuroinflammation|August 24, 2016
Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytesSinead A O'Sullivan, Fabrizio Gasparini, Anis K Mir, et al.
Addiction Biology|March 12, 2011
Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in ratsAmine Bahi, Katharina Fizia, Monika Dietz, et al.
BMC Medical Genetics|March 9, 2012
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitroElisabetta Tabolacci, Filomena Pirozzi, Baltazar Gomez-Mancilla, et al.
Psychopharmacology|December 17, 2004
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in ratsPaul J Kenny, Benjamin Boutrel, Fabrizio Gasparini, et al.
Neuropharmacology|January 16, 2010
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeysNicolas Morin, Laurent Grégoire, Baltazar Gomez-Mancilla, et al.
Neuroimage|February 27, 2019
Inhibiting mGluR5 activity by AFQ056/Mavoglurant rescues circuit-specific functional connectivity in Fmr1 knockout miceValerio Zerbi, Marija Markicevic, Fabrizio Gasparini, et al.
Psychopharmacology|November 16, 2013
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug developmentAndreea S Pop, Baltazar Gomez-Mancilla, Giovanni Neri, et al.
Pageof 7